Hippo Protocol
HP - # 538 ActiveKorean Asset
-
Rating Score 55.50Rating Grade B-
- Rating Version APYWA-v1.1 / Rating Date 2025-12-22
Overview
Hippocrat (HIPC) is a blockchain-based healthcare data management platform designed to securely manage personal health records and improve the efficiency of medical services. Hippocrat stores medical data in a decentralized manner, enabling better healthcare services for patients and promoting collaboration among healthcare institutions. The native token, HIPC, is used within the platform for data transactions, payment of service fees, and participation in governance.
Metric Radar Chart
Metric Bar Chart
Metric Trends
| Total Rating Score | TNNeutral |
|---|---|
| Market Accessibility | TNNeutral |
| Development Activity | TNNeutral |
| Market Liquidity | TNNeutral |
| Community Engagement | TNNeutral |
| Risk & Security | TNNeutral |
Total Rating Score Trend
Market Data
- Token Price $0.020680 (↘1.00%)
- Volume (24h) $1.97M (↗408.15%)
- Market Cap $25.97M (↗2.15%)
-
Circulating Supply
1,255,893,206 HP
1,255,797,445 HP
(Source : Coinmarketcap , Coingecko )
Listed Exchanges
- Korean
-
- Global
-
×
View All Exchanges
- Korean
-
- Global
-
Community Info
X (Twitter) Tweets (Last 30 Days)
22 (-2)
Development Info
-
GitHub Account
hippo-protocol
-
Stars
46 (-)
- Commits (Last 3 Months) 63 (-)
Security Audit Info
- Security Audit Status None
- CertiK Code Security Score 59 pts
(Source : Coinmarketcap , CertiK Skynet )
Issue Info
View Full History
| Category | Date | Exchange | Link | Grade | Details |
|---|---|---|---|---|---|
| Regular Evaluation | 2025-02-13 | - | - | C+(54.20) | [AW-0030-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-02-10 | - | - | C+(54.59) | [AW-0029-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-02-06 | - | - | C+(53.48) | [AW-0028-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-02-03 | - | - | C+(53.96) | [AW-0027-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-01-30 | - | - | C+(52.58) | [AW-0026-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-01-27 | - | - | B-(57.98) | [AW-0025-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-01-23 | - | - | C+(53.69) | [AW-0024-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-01-20 | - | - | C+(54.65) | [AW-0023-정기] 평가가 완료되었습니다. |
| New Listing | 2025-01-16 |  |
 |
- | [빗썸] 거래소에 신규 거래 지원되었습니다. |
| Regular Evaluation | 2025-01-16 | - | - | B-(55.16) | [AW-0022-정기] 평가가 완료되었습니다. |
- Disclaimer
-
The ratings provided by APYWA (hereinafter 'the Company') are conducted via an automated system based on public data and are pure data-driven analysis results with no subjective elements. This rating material includes evaluations on five key metrics: Market Accessibility, Development Activity, Market Liquidity, Community Engagement, and Security. All information provided is for reference purposes only.
Our ratings are not intended as investment advice or recommendations, and we do not guarantee the accuracy, completeness, or timeliness of the information. Users must make their own investment decisions based on the provided data, and the Company bears no legal liability for any resulting losses or damages.
While the rating material is processed automatically based on reliable data, discrepancies with actual market conditions may occur due to data limitations. Therefore, the Company is not liable for any damages arising from the use of the provided information. All information contained herein is the property of the Company and may not be reproduced, distributed, or modified without prior approval.